Objectives Sexual health is defined as a state of physical, emotional, mental and social well-being in relation to sexuality. The impact of inflammatory arthritis (IA) on male sexual health has been mainly studied focusing on erectile function, one of the physical components of sexual health. Our objective was to describe the viewpoints among men with IA in the Netherlands on the overall impact of IA on their sexual health.
Methods Q-methodology, a mixed methods approach to systematically study subjectivity was used. Adult men diagnosed with IA ranked 34 opinion statements about potential impacts of IA on their sexual health and were interviewed. By-person factor analysis was used to identify common patterns in the rankings, which were interpreted as viewpoints. Data from the interviews were used to verify and adjust the interpretations.
Results 30 men (22–77 years) with IA were included. The analysis revealed three viewpoints. Men with the viewpoint ‘Arthritis negatively affects my sexual health’ experience a dramatic impact on all components of sexual health. In viewpoint ‘I am keeping up appearances’, IA negatively impacts sexual health but a distinguishing coping mechanism could mask a more serious negative impact. Men with the viewpoint ‘I am satisfied with my sexual health’' experience no significant impact of IA on their sexual health.
Conclusions We identified three viewpoints on the impact of IA on male sexual health, two revealed a negative influence that goes beyond the physical act of sex. IA can severely affect the emotional, mental and social components of sexual health.
- qualitative research
- patient care team
Data availability statement
All data relevant to the study are included in the article or uploaded as supplementary information.
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Statistics from Altmetric.com
What is already known about this subject?
Most research on the impact of inflammatory arthritis (IA) on male sexual health has focused on the physical aspect of sexual health, in particular erectile dysfunction. These studies have shown that erectile dysfunction is highly prevalent in this population.
What does this study add?
Three viewpoints on the impact of IA on male sexual health were described: ‘Arthritis negatively affects my sexual health’, ‘I am keeping up appearances’ and ‘I am satisfied with my sexual health’.
These viewpoints demonstrated that the impact of IA goes well beyond the physical aspect of sexual health. Mental, emotional and social components of sexual health can also be negatively affected by IA. Although the effect on sexual health can have significant consequences on patients’ lives, this topic was scarcely approached by their healthcare professionals.
How might this impact on clinical practice or future developments?
Since this study revealed that IA can significantly impact multiple components of male sexual health, this topic cannot be neglected any longer. Therefore, efforts should be made to increase awareness and educate healthcare professionals in rheumatology about this topic.
Future research should focus on identifying interventions that can result in preventing or reducing the negative impact of IA on male sexual health. The identified viewpoints could be useful for this purpose.
Sexual health has been defined as a state of physical, emotional, mental and social well-being in relation to sexuality.1 Despite the fact that sexual health is not merely the absence of disease, dysfunction or infirmity, the impact of inflammatory arthritis (IA) on male sexual health has mainly been studied focusing on the association of IA with erectile dysfunction (ED).
ED is a highly prevalent comorbidity in men diagnosed with IA (33%–62%).2 Several factors such as inflammation, alterations in the endocrine axis, adverse events of medication, disability secondary to disease and comorbidities are thought to be responsible for this association. Although male sexual health goes well beyond erectile function and may be impaired by factors such as fears, emotions and beliefs, the impact of IA on the emotional, mental and social components of sexual health has not yet been comprehensively studied.3 4
In order to be able to help men with sexual health problems due to IA, we first need to identify and understand the impact of IA, not only on the physical component but also on the emotional, mental and social components of sexual health.
These components are difficult to analyse and interpret because of their subjective nature. Questionnaires mainly generate quantitative data and can easily miss relevant subjective information. Focus groups provide qualitative data and have been used to explore sexuality.5 Q-methodology combines the strengths of qualitative and quantitative approaches and is a powerful methodology for systematically exploring and explaining patterns in subjectivities (viewpoints, opinions, beliefs) around sensitive topics and identifying consensus and contrasts between them.6 Recently, Q-methodology7–9 has gained attention from researchers in the medical community and has been used to help us better understand complex topics in medicine such as Human Papillomavirus (HPV) vaccination, palliative care, end-stage renal disease and organ donation.10–13 Therefore, Q-methodology can be considered as a suitable method to study the overall impact of IA on male sexual health.
Our objective is to use Q-methodology to describe the viewpoints of adult men with IA concerning the overall impact of IA on their sexual health.
Q-methodology combines qualitative and quantitative techniques to empirically study subjectivity. The whole process of a Q-methodology study can be summarised in four stages (see figure 1).7 Information on the use of Q-methodology in healthcare research can be found elsewhere.14 Furthermore, a checklist to include when reporting a Q-methodology study was included as online supplemental table 1.
Patient and public involvement
Five male patients diagnosed with IA (four were active members of the research advisory board from the Department of Rheumatology of the Erasmus University Medical Center) were involved in the design of the research question, statements, patient information leaflet and invitation letter. During a pilot study four patients evaluated the statement set and the interview materials. Three patients were involved in the interpretation of the results. We carefully assessed the burden on participating patients. We intend to share the results to participating patients and will appropriately disseminate the results.
Men of 18 years or older, diagnosed with IA (rheumatoid arthritis (RA) or polyarticular juvenile idiopathic arthritis (JIA)) were invited to participate by their own rheumatologist. Because our objective was to evaluate the viewpoints of men with IA and the term spondyloarthritis compromises an extensive group of diseases that are associated with a diverse range of extra-articular manifestations (ie, low back pain and psoriatic lesions on the skin) that on their own may negatively impact sexual health,15 16 patients diagnosed with spondyloarthritis were excluded. Therefore, in this study, when referring to IA we focus only on the diagnoses of RA and JIA. Participants were recruited between October 2019 and October 2020, mainly from the general rheumatology and the specialised reproductive rheumatology outpatient clinics from the Erasmus University Medical Center, Rotterdam, the Netherlands. As the aim of the Q-methodology is to explore the variety of viewpoints, not to make claims about the percentage of people expressing them, participants were gathered purposively to ensure diversity. Therefore, recruiters were instructed to invite men with different cultural, religious and socioeconomic backgrounds as well as different sexual orientations. Furthermore, they were also instructed to invite participants of all ages (≥18 year) who were either recently diagnosed with IA (<1 year) or had longer disease duration. To promote diversity, three researchers (LFP-G, ER and RJED) frequently informed recruiters about the progress of inclusion of the participants. In a Q-methodology study it has been recommended to aim to include a number of participants that is smaller than the number of statements.7 Data collection proceeded until saturation was achieved. This was considered to be the case when at least five participants in each of the specified target groups of patients were interviewed and consecutive interviews revealed no significant new viewpoints as compared with earlier interviews.
Statement set development
Two researchers (LFP-G and ER) independently collected candidate statements on how IA can affect the various components of male sexual health (physical, emotional, mental and social factors) based on a non-systematic review of scientific (PubMed), empirical and popular literature (eg, online forums, blogs) on this topic. This process resulted in an initial set of 48 statements.
To evaluate its comprehensibility and comprehensiveness, the set was discussed with five male patients diagnosed with IA, one expert in the field of reproductive rheumatology (RJED) and two experts in the field of sexology (HP and JMB). In addition, one expert in the field of Q-methodology (JvE) was consulted to provide methodological advice on the selection and formulation of statements. Following these discussions, a number of adjustments were made: some statements were excluded from the initial set because they covered similar topics (see online supplemental table 2) and the wording of several statements was revised. At the end of this phase, a draft set of 34 statements remained for pilot testing.
To ensure the comprehensiveness and comprehensibility of the statement set and other interview materials, a pilot study involving four male patients with IA was conducted. Based on its results, no modifications to the interview materials, including the statement set were deemed necessary. Therefore, the four participants from the pilot study could be retained for the main study. The final statement set (translated into English), is presented in table 1. The original statement set (in Dutch) can be found in online supplemental table 3.
Participants were invited for an individual interview in the Erasmus MC, which took approximately 1 hour. Because of the impact of the COVID-19 pandemic, five interviews were conducted using online meeting platforms.
Each session was moderated by LFP-G and ER and started with instructions on the sorting of the statements and an explanation of the concept of sexual health as being a comprehensive term that goes beyond the physical act of sex.
Thereafter, participants were presented with the 34 statements printed on cards, in random order, and asked to carefully read all cards. They were asked to consider each statement in relation to the question ‘How does arthritis impact your sexual health?’ and sort them into three piles representing statements they agreed with, disagreed with and found to be neutral or irrelevant. The participants were then instructed to reread the cards in each pile prior to ranking them on the sorting grid. They started with the agree pile, followed by the disagree pile and finally the neutral pile (see figure 2).
After ranking the statements, participants were asked open-ended questions. They were asked to explain the placement of certain statements on the sorting grid and all participants elaborated on the two statements with which they most agreed and disagreed. Also, they were invited to discuss any statement they found interesting. At the end of the interview, participants were asked to briefly describe their opinion about the overall impact of IA on their sexual health in their own words. The interviews were voice recorded.
Finally, participants were asked to fill in a questionnaire, which included questions regarding their demographic characteristics, disease activity scores (Health Assessment Questionnaire-Disability Index (HAQ-DI), Rheumatoid Arthritis Disease Activity Index (RADAI), Visual Analogue Scale (VAS)-general health, VAS-disease activity, VAS-pain, VAS-fatigue) and the Patient Health Questionnaire-9 (PHQ-9) for depression screening.
Participants received financial compensation for their travel and parking costs.
Individual statement rankings were subject to by-person factor analysis (ie, centroid factor extraction, followed by varimax rotation) using PQMethod V.2.35. Identified factors, with eigenvalue larger than one and at least two participants significantly associated (p<0.05), were interpreted as viewpoints on the overall effect of IA on male sexual health. Interpretations were based on composite (ie, weighted average) statement rankings for each factor. Inspection of statistical information (ie, explained variance and number of defining variables per factor) and the coherence and interpretability of the factors, also consulting the qualitative materials collected during the interviews, resulted in the choice for a three-factor solution. Consensus statements (ie, those whose rankings did not differ significantly between any pair of viewpoints) and distinguishing statements (ie, those whose rankings in one viewpoint differed significantly from those in all other viewpoints) were identified.
The interpretation and description of each viewpoint were supplemented with the answers to the open-ended questions from participants whose rankings were associated with that viewpoint (p<0.05).
Forty-seven men were invited to participate in the study. The final sample consisted of 30 men with IA (response rate of 64%). Their mean age was 43.2 (range 22–77) years and had a mean disease duration of 15.25 (SD 10.88) years. Most of the participants were Dutch (86.6%), sexually active during the last year (92.8%) and in a relationship (96.6%). Demographic characteristics of the study population are presented in table 2.
The analysis revealed three viewpoints. Twenty-four participants were significantly associated with one of these viewpoints (p<0.05). The viewpoints explained 50% of the variance in the ranking data and table 1 shows the composite rankings of the statements for each of the three viewpoints together with the distinguishing and consensus statements.
Viewpoint 1: ‘Arthritis negatively affects my sexual health’
Men with this viewpoint experience a substantial impact of IA on their sexual health. In particular, pain (st.6:+4; ie, statement 6 receives factor score +4), fatigue (st.7:+4) and gloom (st.8:+2) secondary to IA had a negative influence on their sexual health. They feel unsatisfied with their sexual health (st.1:−2) and consider that their sexual problems are not the same as those present in healthy men (st.11:−4). Due to IA, sex became less spontaneous (st.9:+2), unpredictable (st.10:+3) and difficult (st.15:+3); ‘Because of pain, my sex life became more conservative than it was’ (45 years, diagnosed with RA at the age of 35).
Although, they acknowledge that IA is associated with problems of getting and/or maintaining an erection (st.16:+1), these men strongly disagreed with the fact that IA reduces their sexual thoughts (st.12:−3), arousal (st.13:−1) and their sexual desire (st.14:−2) indicating that their sexual dysfunction is mainly due to ED and not due to impaired desire and arousal.
The effect that IA has on these men’s sexual health also impacts the relationship with their partners. Guilt towards their partners (st.29:+3) and the feeling of not being completely understood by their partners (st.33:+1) could explain why these men feel that their relationship with their partners worsened because of the diagnosis of IA (st.32:−1). As one participant said ‘All of my relationship problems are because of my arthritis’ (48 years, diagnosed with RA at the age of 44).
With regards to communication, this group of men identified themselves as ‘open people’. They find it easy to talk about their sexual health with their partners (st.27:−2) and healthcare professional (st.24:−1). Nonetheless, they expressed that getting access to information regarding this topic was difficult. This was exemplified by one of the most frequently expressed comments: ‘My doctor is always busy and has no time for this’ (61 years, diagnosed with RA at the age of 42). Finding information online about this topic was considered as ‘easy’, but not always adequate and therefore not their preferred method to get information (st.25:−1).
Their masculinity (st.19:0) and attractiveness (st.20:+1) were slightly negatively influenced by IA. Notably, this was also associated with a negative effect on their confidence with regards to sex (st.21:+2): ‘I have never found myself attractive, I got deformities that no one else got’ (48 years, diagnosed with JIA at the age of 1). During the interviews, several men also expressed a feeling of frustration and fear towards the idea of not being the partner and/or the father they would like to be. ‘She can get better than me’ and ‘I’m afraid of not being able to play football with my son’ (40 years, diagnosed with RA at the age of 34).
Viewpoint 1 had an eigenvalue (‘characteristic value’) of 2.94 and explained 10% of the variance in the ranking data. Six participants (20%) were significantly associated with this viewpoint.
Viewpoint 2: ‘I am keeping up appearances’
This group of men also experiences a negative effect of IA on their sexual health. The diagnosis of IA changed their sexual health (st.4:+2). This was mainly due to pain (st.6:+4), which limits their physical abilities (st.15:+1). Furthermore, sex became less frequent (st.9:+1) and they enjoy sex less (st.3:+1).
Other factors such as fatigue (st.7:0) and gloom (st.8:–1) were not considered to have negative effects on their sexual health. In addition, IA has no negative effect on their capacity to get or maintain an erection (st.16:−4) or on their sexual desire (st.14:−1), reflecting a pure ‘physical/mechanic’ negative effect of pain on their sex lives. For these men, sex is considered as important contributor to their quality of life (st.2:+3) and they feel satisfied with their sexual health (st.1:+3).
A distinguishing factor of this group was that these men feel less attractive because of their IA (st.20:+2). During the interviews it became evident that for some men this was directly associated with physical deformities; ‘Every day I am thinking about that (his deformities)’ (33 years, diagnosed with JIA at the age of 1) or ‘It is awkward to get naked in front of your partner when you have swollen joints’ (34 years, diagnosed with JIA at the age of 12). For other men, feeling less attractive was associated with their incapacity to perform physical skills (general and during sex), which also has a negative effect on their level of self-confidence.
Another distinguishing factor associated with this group was that these men feel that their partners understand their sexual problems (st.33:+4 and st.34:−3) although it was not always easy for them to discuss these issues with them (st.27:0). The impact of IA on their feelings/beliefs about being a man (masculinity) varied between these men (st.19:−1). During the interviews it became evident that their masculinity is a significant contributor to their quality of life that further defines this viewpoint; ‘Being a man is more than just physical, it is also mental, that is why sometimes I don’t tell my wife that I am in pain, I am keeping up appearances’ (36 years, diagnosed with RA at the age of 35). These men also described they had problems accepting their disease and communicating their sexual health problems to others ‘I want to keep everything normal, like it was before’ (36 years, diagnosed with RA at the age of 35). As a result, these men tend to hide their problems.
As was the case for viewpoint 1, participants associated with this viewpoint considered that the limited time, that rheumatologists have during their regular appointments, was also the most important reason why talking about sexual health with a healthcare provider is difficult (st.24:+1). Currently, most of the participants in this group agreed with the idea that they might not feel the need to discuss this issue with healthcare professionals (st.23:0). However they also indicated that it would have been helpful to receive proper information and advice earlier in their lives.
Viewpoint 2 had an eigenvalue of 1.55 and explained 5% of the variance. Five participants (17%) were significantly associated with this viewpoint.
Viewpoint 3: ‘I am satisfied with my sexual health’
Men with this viewpoint were satisfied with their sexual health (st.1:+4) and considered sex as an important contributor to their quality of life (st.2:+4). In addition, arthritis did not change their sexual health (st.4:−1), had no negative effect on their erectile function (st.16:−4), sexual desire (st.12:−2, st.13:−3 and st.14:−2) or the frequency of sex (st.9:−1).
Gloom and fatigue had the most significant negative influence (st.7:+3 and st.8:+3) on their sexual health. Notably, during the interviews, both statements were mostly defined as being associated with their ‘normal life’ and not specifically with IA. Pain also has a minor negative effect on their sex lives (st.6:+1). Nonetheless, the effect of pain varies between periods of high and low disease activity; ‘If I had filled this grid 10 years ago it would have been completely different. Back then, pain had a major effect on my sex life’ (62 years, diagnosed with RA at the age of 42).
These men believe that their sexual problems are the same as those present in healthy men (st.11:+3). Furthermore, this statement was also associated with episodes of their lives where they have low disease activity or are in clinical remission; ‘I have no pain now and I feel like a healthy man’ (31 years, diagnosed with RA at the age of 22) or with certain attitudes towards the disease itself ‘I want to be a healthy man’ (74 years, diagnosed with RA at the age of 59). Their masculinity and feelings of attractiveness are not (or no longer) significantly impacted by the diagnosis of IA (st.19:−2 and st.20:−3).
Other themes that emerged within this viewpoint were that these men believe that their relationships with their partners improved after receiving the diagnosis of IA (st.32:+2), that their partners understand their sexual problems (st.33:+2) and intimacy became more important than sex (st.30:+1).
Communication with their partners about this topic is not considered to be difficult (st.27:−3); ‘The diagnosis of arthritis opened the doors to us discussing other stuff’ (36 years, diagnosed with RA at the age of 30). With regards to communication with healthcare professionals (st.24:+1), they prefer to get information about this topic online (st.25:+2).
For these men, it is important to consider their sexual health when taking decisions about their medical treatment (st.22:+2). This was of special importance when these men have an active wish to become a father.
Viewpoint 3 had an eigenvalue of 10.35 and explained 35% of the variance. Thirteen participants (43.3%) were significantly associated with this viewpoint.
Demographic and clinical differences between the viewpoints
Although the design of this study was not intended to draw epidemiological conclusions, the differences in the demographic and clinical characteristics of the participants across the three viewpoints are worth mentioning (see tables 2 and 3).
One of the most striking differences is that compared with men identified with viewpoints 2 and 3, men identified with viewpoint 1 received the diagnosis of IA at a younger age (28.6 vs 31.1 vs 15.5 years, respectively).
Furthermore, compared with men associated with viewpoint 3, men associated with viewpoints 1 and 2 reported higher disease activity. Noteworthy, men associated with viewpoint 1 reported more depressive symptoms while men associated with viewpoint 2 reported higher pain scores (see table 3).
Although the WHO has indicated that sexual health goes well beyond the absence of disease1 and others have recommended evaluating sexual health using a more holistic approach,17 so far the impact of IA on male sexual health has been mainly studied focusing on ED. Using Q-methodology, we addressed these recommendations and identified three viewpoints on the overall impact of IA on male sexual health among adult men in: ‘Arthritis negatively affects my sexual health’, ‘I am keeping up appearances’ and ‘I am satisfied with my sexual health’.
A negative impact of IA on male sexual health was described in viewpoints 1 and 2. Understanding the different characteristics between these two viewpoints is an important first step towards identifying and approaching these patients.
A severe and ‘full’ effect of IA on sexual health was identified in viewpoint 1 (‘Arthritis negatively affects my sexual health’). Not only were these men characterised by the fact that they clearly attributed their erectile problems to the diagnosis of IA but they also described how multiple characteristics of IA significantly impacted all components of sexual health: physical (pain and fatigue), emotional (feeling guilty towards their partners, lower self-confidence), mental (higher PHQ-9 scores) and social (problems with partners). These men were younger, had a longer disease duration, reported lower general health and had more depressive symptoms. Altogether this might suggest that men diagnosed with IA at an early age might be particularly vulnerable to experience a negative effect of IA on their sexual health. Men with this viewpoint expressed their willingness to talk about and seek help concerning their sexual health problems.
In contrast, men with viewpoint 2 (‘I am keeping up appearances’) experience milder and mainly physical sexual problems. These problems were mainly associated with pain and were considered a difficult topic to discuss. Although they indicated that IA changed their sexual life and they enjoy sex less because of the diagnosis of IA, these men also agreed with the statement that they feel satisfied with their sexual health. A potential explanation for this discrepancy in the quantitative data was provided by the men during the interviews. These qualitative data revealed a stronger and more complex negative effect of IA on male sexual health and a distinguishing coping mechanism that these men have in relation to the diagnosis of IA and/or living with IA. Compared with women, men with RA struggle more often to accept and cope with their diagnosis.18–20 Using Q-methodology, two different coping strategies in men with RA were previously described; ‘acknowledge, accept and adapt’ and ‘trying to match up to a macho ideal’.21 Men with viewpoint 2 share many distinguishing factors with the coping strategy ‘trying to match up to a macho ideal’, which further supports the theory that some men tend to hide their feelings of vulnerability (‘I am a man’). This attitude may result in difficulties for healthcare professionals to address the needs of their patients adequately, as they may miss important internal distress experienced by their patients. Therefore, identifying these men can be considered a challenge and requires a special approach. Instead of asking them whether they feel satisfied with their sexual health or if they have sexual health problems (ie, erectile dysfunction), these men are more receptive to questions such as; did IA change your sexual health? or, is IA interfering with your ability to enjoy sex?
Men with viewpoint 3 (‘I am satisfied with my sexual health’) indicated that they were satisfied with their sexual health and considered their sexual health problems as not being different from those of healthy men. These men associated their degree of satisfaction with their current states of clinical remission or low disease activity. Their interviews provided us with an important message about the potential dynamics of the viewpoints. Participants described how ranking the statements would have been different if they participated during a period with higher disease activity. In the past, during such periods IA did impair their sexual health, which resulted in dissatisfaction. This was usually solved when low disease activity or remission was achieved. With this regard, it has been previously reported that improvement in disease activity has been associated with improved sexual function22 and with a better quality of life.23
Participants across the three viewpoints also pointed out that their ranking of the statements would have been different if they would have participated during a different phase of their life (ie, adolescence/young adulthood). As an example, men who were diagnosed at a younger age described how exploring their sexuality was difficult and different compared with ‘other boys’, how their diagnosis led to problems in their relationships during their early dating years. They also described long-term consequences of the diagnosis of IA, for instance how IA interfered with their sexual development and how certain bodily malformations secondary to IA can have a long-lasting significant psychological impact on their daily lives.
In general, and similar to other chronic conditions,24–26 there was broad consensus among participants that independent of their age or health perception, sexual health is an important contributor to their quality of life. Furthermore, most participants agreed that sexual health is not only important when having an active desire to become a father. Most patients disclosed that receiving information and advice about sexual health in relation to their IA would have been helpful. They also reflected on the importance of approaching sexual health during different phases of life as well as different stages of the disease itself. This has also been reported for similar chronic musculoskeletal conditions affecting sexual health.27 They were open to discuss sexual health with their healthcare professionals, but this issue was hardly ever raised by healthcare professionals.
Several explanations for this communication gap between healthcare professionals and patients have been described.28 First, healthcare professionals generally incorrectly believe that sexual health is not as crucial as other topics or that patients do not expect them to discuss sexual concerns.29 Notwithstanding, as an important contributor to the quality of life of men with IA, and in line with recommendations,30 male sexual health should be periodically raised by healthcare professionals in consultations with their patients. As it has been reported in the literature, it is important to consider that the majority of patients prefers active inquiry about sexual health from their healthcare professionals.31 Concerning this, most participants expressed their gratitude to the research team for ‘starting the conversation’ by inviting them to take part in the study. They described how participating in this study was a positive experience that allowed them to better understand how IA had impacted (or not) their sexual health, and lead them to discuss this topic with their partners.
Second, limited time during the consultation was described as one of the most important barriers to discuss this topic with healthcare professionals. Increased awareness of this problem, pre-consultation questionnaires for patients and a dedicated teamwork effort between all healthcare professionals involved in the care of men with IA (General practitioners, rheumatologists, nurses, psychologists, sexologists, etc) can result in an efficient method to approach this topic.
Lastly, another important barrier is that healthcare professionals often feel unprepared or lack the necessary knowledge to raise and discuss this topic with their patients.32 The Permission, Limited, Information, Specific Suggestions and Intensive Therapy model can be used by healthcare professionals to facilitate their evaluation of sexual health.33 34 Importantly, sexual health assessment (in the clinic and in research) should be broad and not only focus on the presence or absence of erectile dysfunction. Tailor-made educational programmes about sexual health should be designed and disseminated among healthcare professionals in the field of rheumatology.
Our study has several strengths. By combining qualitative and qualitative data using Q-methodology we were able to describe the impact of IA on many components of sexual health. This allowed us to identify multiple characteristics that could have been easily missed by conventional questionnaires or screening tools and that were crucial to understand the impact of IA on male sexual health and that are relevant for the patients and their quality of life. Furthermore, to ensure a representative and relevant outcome, a multidisciplinary approach that included the input from patients and experts from several fields was used during the design, conduction and interpretation of the study.
An important limitation of this study is that the group of men included was not as diverse as the general population of men with IA. In particular, single men, of non-Dutch ethnic background, non-heterosexual and devout or very religious were difficult to recruit. In addition, the response rate of 64%, although higher than expected, does not exclude the possibility of having missed participants with communication problems or who specifically did not want to talk about sexual health. This means that additional viewpoints, particular to these groups, may have been missed. Moreover, this study was conducted in the Netherlands and the findings are thus confined to the specific sociocultural and healthcare system characteristics in this country. Similar studies in other countries may reveal partly different viewpoints, with insights that are relevant in their specific patient population and clinical and social context. Replication is therefore recommended, after careful consideration of the comprehensiveness of the set of statements for local use. Although the results of this study are not generalisable to different populations, they do highlight that research into this topic and raising issues with sexual health in clinical practice may be relevant in other populations as well.
Future research should focus on identifying the prevalence of the three viewpoints in a larger population and better characterising the clinical characteristics and predictors of impaired sexual health in men with IA. Furthermore, prospective studies on whether and to what extent these viewpoints change in association with disease activity and duration, antirheumatic therapy and/or the patients’ age are encouraged. Ideally, such studies will provide us with enough information to elaborate questionnaires or diagnostic tools that can facilitate the identification of patients with IA and impaired sexual health. Moreover, the development of efficient intervention strategies to prevent and treat sexual health problems in men with IA are needed. To this end, multidisciplinary collaboration with fields such as sexology, psychology and andrology is recommended. Establishing these research strategies will not only result in an increased awareness of this problem among the rheumatology community but can also stimulate healthcare professionals to ‘start the conversation’ and to talk about sexual health with their patients.
Our study confirms that sexual health is important for men with IA and that the overall impact of IA on their sexual health is significant and goes well beyond erectile problems.
Data availability statement
All data relevant to the study are included in the article or uploaded as supplementary information.
Patient consent for publication
This study was reviewed by the Medical Ethics Committee of the Erasmus University Medical Centre. The committee declared that the rules laid down in the Medical Research Involving Human Subjects Act do not apply to this study. Written informed consent was obtained from all participants.
Contributors All authors met the authorship criteria, they had a substantial contribution to the conception or design of the work (all authors) or the acquisition (LFP-G, ER and RJED), analysis (LFP-G, ER, JvE and RJED) or interpretation of data for the work (all authors) and were involved in revising a draft of this work, gave final approval of this version to be published and are accountable for all aspects of the work in ensuring accuracy and integrity.
Funding This work was supported by research grants from the Dutch Arthritis Foundation (ReumaNederland) (project number: 16-3-402), ZonMw (project number 849200009) and Consejo Nacional de Ciencia y Tecnologia (CONACYT) (project number 601574). All are non-profit organisations.
Competing interests LFP-G Consultant of: Galapagos, ER: None declared, HP: None declared, JMB: None declared, JvE: None declared, RJED Speakers bureau: UCB, Roche, AbbVie, Genzyme, Novartis, Consultant of: Galapagos, Grant/research support from: UCB.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.